Tag: iSpecimen
Interview with Jill Mullan, Chief Operating Officer at iSpecimen
Every medical breakthrough starts with the study of afflicted patients, often through their blood, tumor tissue, or other biological material. Thus, it’s critical for the advancement of life science research that scientists can easily procure the human biospecimens they...
